Pay in 4 interest-free payments of $6.92 Learn more
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9
Their small size and efficacy at relatively low concentrations, and higher efficacy over the antibody Solanezumab in our assay, together with a lack of immunological effector functions as well as interactions with plasma proteins 24 , make the A-anticalin a potential candidate drug for further investigation as a possible therapeutic entity for the preventive treatment of early AD
Caiment, F., Gaj, S., Claessen, S
Molecular classification of bladder urothelial carcinoma using nanostring-based gene expression analysis
H., Chicco, A
Start your consultation to explore a more controlled, long-term approach to GLP-1 therapy
US$ 27.53
US$ 25.54
US$ 29.17
US$ 24.90
US$ 29.67
US$ 23.70
